Hernández Olmos, VíctorVíctorHernández OlmosHeering, JanJanHeeringProschak, EugenEugenProschakSteinhilber, DieterDieterSteinhilberWeigert, AndreasAndreasWeigert2025-07-272025-07-272025-04-30https://publica.fraunhofer.de/handle/publica/489993Herein, compounds of Formulae (I-a) and (II) that act as selective agonists of the leukotriene B4 receptor 2 (BLT2) receptor are presented. The invention pertains to these compounds, their synthesis, as well as their medical use, amongst others in the treatment of pain and inflammatory skin diseases such as psoriasis.enpatentEP4545138 A1EP20230205641